Children with a genetic risk of developing myelodysplastic syndromes (MDS) and other hematopoietic malignancies (HM), such as leukemias...

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute found a small set of proteins that maintain...

The addition of bortezomib to chemotherapy significantly improved survival outcomes among children and young adults with T-cell ...

A recent study involving children with hematologic malignancies has suggested that mutations in a portion of a cohesin gene known as...

Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with...

Two new Yale-led studies elucidate protein structure and function of ALK, a protein receptor, which could contribute to new treatments...

New FDA approval means that pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lympoblastic lymphoma who are...

"Despite receiving no neurotoxic therapy directed to the central nervous system, long-term survivors of childhood Hodgkin lymphoma (HL)...

Adding rituximab (Rituxan, Truxima) to chemotherapy may be a new standard for treating children and young adults newly diagnosed with...

It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt...